Literature DB >> 17618595

Anion exchange fractionation of serum proteins versus albumin elimination.

Ziad J Sahab1, Kenneth A Iczkowski, Qing-Xiang Amy Sang.   

Abstract

Elimination of albumin, constituting more than 50% of total serum proteins, allows increased protein loads on immobilized pH gradient (IPG) gels and better visualization of low-abundance proteins; however, it may result in the loss of albumin-bound low-abundance proteins. In this study, we report the prefractionation of serum proteins by batch anion exchange chromatography into three fractions: one containing proteins with isoelectric points (pI values) higher than the pI of albumin, a second fraction containing proteins with pI values in the same range as the pI of albumin, and a third fraction containing proteins with pI values lower than the pI of albumin. This procedure uses common instrumentation, is carried out under denaturing conditions, and takes less than 30min. We also report the loss of a clinically established prostate cancer serum biomarker, prostate-specific antigen (PSA), after albumin is eliminated using two commercially available albumin elimination kits: one that uses Cibacron Blue F3GA, which achieves albumin depletion through dye-ligand binding, and one that uses specific albumin antibody. The loss of PSA secondary to albumin elimination exceeded that after batch anion exchange serum sample prefractionation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618595     DOI: 10.1016/j.ab.2007.06.004

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Microfluidic enrichment of small proteins from complex biological mixture on nanoporous silica chip.

Authors:  Ye Hu; Ashwini Gopal; Kevin Lin; Yang Peng; Ennio Tasciotti; Xiaojing John Zhang; Mauro Ferrari
Journal:  Biomicrofluidics       Date:  2011-03-30       Impact factor: 2.800

2.  Depletion of plasma albumin for proteomic analysis of Bothrops jararaca snake plasma.

Authors:  Karen de Morais-Zani; Kathleen Fernandes Grego; Aparecida Sadae Tanaka; Anita Mitico Tanaka-Azevedo
Journal:  J Biomol Tech       Date:  2011-07

3.  Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS.

Authors:  Annemieke W J Opstal-van Winden; Jos H Beijnen; Arnoud Loof; Waander L van Heerde; Roel Vermeulen; Petra H M Peeters; Carla H van Gils
Journal:  J Clin Lab Anal       Date:  2012-01       Impact factor: 2.352

4.  Non-receptor tyrosine kinase 2 reaches its lowest expression levels in human breast cancer during regional nodal metastasis.

Authors:  Qing-Xiang Amy Sang; Yan-Gao Man; You Me Sung; Zahraa I Khamis; Lihua Zhang; Mi-Hye Lee; Stephen W Byers; Ziad J Sahab
Journal:  Clin Exp Metastasis       Date:  2011-11-25       Impact factor: 5.150

5.  Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype.

Authors:  Ziad J Sahab; Yan-Gao Man; Suzan M Semaan; Robert G Newcomer; Stephen W Byers; Qing-Xiang Amy Sang
Journal:  Clin Exp Metastasis       Date:  2010-07-03       Impact factor: 5.150

6.  Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle.

Authors:  Ziad J Sahab; Michael D Hall; You Me Sung; Sivanesan Dakshanamurthy; Yun Ji; Deepak Kumar; Stephen W Byers
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

7.  Protein profiling of isolated leukocytes, myofibroblasts, epithelial, Basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues.

Authors:  Zahraa I Khamis; Kenneth A Iczkowski; Ziad J Sahab; Qing-Xiang Amy Sang
Journal:  J Cancer       Date:  2010-06-15       Impact factor: 4.207

8.  Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26.

Authors:  Ziad J Sahab; Michael D Hall; Lihua Zhang; Amrita K Cheema; Stephen W Byers
Journal:  J Cancer       Date:  2010-06-02       Impact factor: 4.207

9.  Highly efficient human serum filtration with water-soluble nanoporous nanoparticles.

Authors:  Antonella Pujia; Francesco De Angelis; Domenica Scumaci; Marco Gaspari; Carlo Liberale; Patrizio Candeloro; Giovanni Cuda; Enzo Di Fabrizio
Journal:  Int J Nanomedicine       Date:  2010-11-19

Review 10.  Putative biomarkers and targets of estrogen receptor negative human breast cancer.

Authors:  Ziad J Sahab; Yan-Gao Man; Stephen W Byers; Qing-Xiang A Sang
Journal:  Int J Mol Sci       Date:  2011-07-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.